OTC: IPSEY - Ipsen S.A.

Yield per half year: -6.67%
Sector: Healthcare

Ipsen S.A.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
8/10
13.87 31.46 -55.91% -4.01 -445.61%
P/S 2.86 3.24 -11.73%
P/BV 2.34 3.36 -30.38%
P/FCF 14.7 21.26 -30.84%
Ev/Ebitda 9.39 9.95 -5.67%
Ev/S 2.84 1.89 50.05%
Ev/FCF 13.44 19.93 -32.56%
E/P 0.0664 1.47 -95.48%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
9/10
30.23 24.35 24.18% 32.99 -8.37%
ROE 16.85 13.19 27.72%
ROA 10.19 6.14 66.06%
ROIC 0 15.56 -100%
ROS 20.6 12.56 64.02%
ROCE 16.97 14.36 18.2%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0.4137 6.21 -93.34% 0.4668 -11.36%
Nеt Debt/Ebitda -0.0693 -5.72 -98.79%
Debt/Ratio 0.0619 0.2122 -70.84%
Debt/Equity 0.1487 12.45 -98.81%
Debt/Net Income 0.6071 15.05 -95.97%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
2.5/10
0.996 1.72 -42.22% 1.18 -15.37%
Number of years of dividend growth 1 1.27 -21.11%
DSI 0.8571 0.7793 9.99%
Average dividend growth -135424.99 -270.17 50026.26%
Average percentage for 5 years 1.18 2.79 -57.87%
Average percentage for payments 905.09 246.79 266.75%
Difference from average difference in sector -0.7277

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
4/10
22.79 140.59 -83.79%
Growth impulse Ebitda in 5 years 4.08 107.17 -96.19%
Growth impulse Net Income in 5 years -1205.32 123.16 -1078.66%
Growth impulse FCF in 5 years 96.77 93.68 3.3%
Growth impulse EPS in 5 years 67.67 229.02 -70.45%
IP Score
5.91/10

Similar companies

WuXi Biologics (Cayman) Inc.

Sinopharm Group Co., Ltd.

Roche Holding

Sinopharm Group Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription